An FDA advisory panel voted 8-0, with one abstention, to recommend updating COVID-19 vaccines for the 2026-27 season to target the dominant XFG variant, despite concerns from some members about ...
The U.S. Food and Drug Administration (FDA) has approved the latest version of Pfizer and BioNTech's COVID-19 mRNA vaccine, specifically designed to target the dominant XFG variant, for use in adults ...
The Food and Drug Administration on Thursday green-lit updated coronavirus vaccines for higher-risk Americans, such as older adults and people with at least one underlying health condition, vaccine ...
An HHS spokesperson confirmed the studies were withdrawn. FDA blocked the publication of studies that tracked the safety of the COVID-19 and shingles vaccines, an official told ABC News. The Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results